Sam Chun Dang Pharm. Co. Ltd.
3 clinical trials · Sponsor
◉ Watch Sam Chun Dang Pharm. Co. Ltd.
| Record | Firm | Date |
|---|---|---|
| Bioavailability, Biopotency and Food Effect Study of SCD0503 Compared to Subcutaneous Regular Human Insulin (NCT07634770) | Sam Chun Dang Pharm. Co. Ltd. | 2026-05-29 |
| Study of the SCD411 Prefilled Syringe for Treating Adults With Wet Age-Related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema, or Diabetic Retinopathy (NCT07501052) | Sam Chun Dang Pharm. Co. Ltd. | 2026-05-13 |
| A Study to Comparing SCD411 and Eylea® in Subjects With Wet Age-related Macular Degeneration (AMD) (NCT04480463) | Sam Chun Dang Pharm. Co. Ltd. | 2020-08-13 |
Track Sam Chun Dang Pharm. Co. Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.